nodes	percent_of_prediction	percent_of_DWPC	metapath
Codeine—UGT2B7—Zidovudine—acquired immunodeficiency syndrome	0.0617	0.0774	CbGbCtD
Codeine—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.041	0.0514	CbGbCtD
Codeine—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.0398	0.0499	CbGbCtD
Codeine—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.036	0.0452	CbGbCtD
Codeine—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0298	0.0374	CbGbCtD
Codeine—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0298	0.0374	CbGbCtD
Codeine—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.0267	0.0335	CbGbCtD
Codeine—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0257	0.0323	CbGbCtD
Codeine—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0257	0.0323	CbGbCtD
Codeine—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.025	0.0313	CbGbCtD
Codeine—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.025	0.0313	CbGbCtD
Codeine—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0247	0.031	CbGbCtD
Codeine—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0226	0.0283	CbGbCtD
Codeine—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0226	0.0283	CbGbCtD
Codeine—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0226	0.0283	CbGbCtD
Codeine—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0226	0.0283	CbGbCtD
Codeine—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0224	0.028	CbGbCtD
Codeine—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0224	0.028	CbGbCtD
Codeine—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0193	0.0242	CbGbCtD
Codeine—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0187	0.0235	CbGbCtD
Codeine—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0169	0.0213	CbGbCtD
Codeine—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0169	0.0213	CbGbCtD
Codeine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0161	0.0202	CbGbCtD
Codeine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0152	0.019	CbGbCtD
Codeine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0152	0.019	CbGbCtD
Codeine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0137	0.0172	CbGbCtD
Codeine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0137	0.0172	CbGbCtD
Codeine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0118	0.0148	CbGbCtD
Codeine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0115	0.0144	CbGbCtD
Codeine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0104	0.013	CbGbCtD
Codeine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0104	0.013	CbGbCtD
Codeine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0103	0.0129	CbGbCtD
Codeine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00964	0.0121	CbGbCtD
Codeine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00964	0.0121	CbGbCtD
Codeine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00872	0.0109	CbGbCtD
Codeine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00872	0.0109	CbGbCtD
Codeine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00753	0.00944	CbGbCtD
Codeine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00731	0.00917	CbGbCtD
Codeine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00661	0.00829	CbGbCtD
Codeine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00661	0.00829	CbGbCtD
Codeine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00633	0.00795	CbGbCtD
Codeine—OPRM1—nerve—acquired immunodeficiency syndrome	0.00174	0.117	CbGeAlD
Codeine—UGT2B4—lung—acquired immunodeficiency syndrome	0.00115	0.0774	CbGeAlD
Codeine—UGT2B7—digestive system—acquired immunodeficiency syndrome	0.000757	0.051	CbGeAlD
Codeine—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000715	0.0482	CbGeAlD
Codeine—OPRD1—nervous system—acquired immunodeficiency syndrome	0.000574	0.0387	CbGeAlD
Codeine—OPRD1—central nervous system—acquired immunodeficiency syndrome	0.000553	0.0372	CbGeAlD
Codeine—OPRK1—nervous system—acquired immunodeficiency syndrome	0.000551	0.0371	CbGeAlD
Codeine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000537	0.0361	CbGeAlD
Codeine—OPRK1—central nervous system—acquired immunodeficiency syndrome	0.00053	0.0357	CbGeAlD
Codeine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000528	0.0356	CbGeAlD
Codeine—OPRM1—blood—acquired immunodeficiency syndrome	0.000483	0.0325	CbGeAlD
Codeine—OPRD1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.000474	0.0278	CbGpPWpGaD
Codeine—OPRM1—spinal cord—acquired immunodeficiency syndrome	0.000465	0.0313	CbGeAlD
Codeine—OPRD1—brain—acquired immunodeficiency syndrome	0.000439	0.0296	CbGeAlD
Codeine—SLC22A1—blood—acquired immunodeficiency syndrome	0.000431	0.0291	CbGeAlD
Codeine—OPRK1—brain—acquired immunodeficiency syndrome	0.000421	0.0283	CbGeAlD
Codeine—OPRK1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.000416	0.0244	CbGpPWpGaD
Codeine—SLC22A1—vagina—acquired immunodeficiency syndrome	0.0004	0.0269	CbGeAlD
Codeine—OPRM1—nervous system—acquired immunodeficiency syndrome	0.000392	0.0264	CbGeAlD
Codeine—OPRM1—central nervous system—acquired immunodeficiency syndrome	0.000377	0.0254	CbGeAlD
Codeine—OPRD1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000368	0.0216	CbGpPWpGaD
Codeine—OPRM1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.000351	0.0206	CbGpPWpGaD
Codeine—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.00035	0.0236	CbGeAlD
Codeine—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.000337	0.0227	CbGeAlD
Codeine—OPRK1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000323	0.0189	CbGpPWpGaD
Codeine—OPRM1—brain—acquired immunodeficiency syndrome	0.000299	0.0202	CbGeAlD
Codeine—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000275	0.0185	CbGeAlD
Codeine—OPRM1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000273	0.016	CbGpPWpGaD
Codeine—SLC22A1—brain—acquired immunodeficiency syndrome	0.000268	0.018	CbGeAlD
Codeine—OPRD1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.000265	0.0155	CbGpPWpGaD
Codeine—CYP3A5—blood—acquired immunodeficiency syndrome	0.000262	0.0176	CbGeAlD
Codeine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000259	0.00151	CcSEcCtD
Codeine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000259	0.00151	CcSEcCtD
Codeine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000258	0.00151	CcSEcCtD
Codeine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000258	0.00151	CcSEcCtD
Codeine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000257	0.0015	CcSEcCtD
Codeine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000256	0.0015	CcSEcCtD
Codeine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000256	0.0015	CcSEcCtD
Codeine—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000255	0.00149	CcSEcCtD
Codeine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000255	0.00149	CcSEcCtD
Codeine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000254	0.00148	CcSEcCtD
Codeine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000253	0.00148	CcSEcCtD
Codeine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000253	0.00148	CcSEcCtD
Codeine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000253	0.00148	CcSEcCtD
Codeine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000251	0.00147	CcSEcCtD
Codeine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00025	0.00146	CcSEcCtD
Codeine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00025	0.00146	CcSEcCtD
Codeine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00025	0.00146	CcSEcCtD
Codeine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000249	0.00146	CcSEcCtD
Codeine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000249	0.00146	CcSEcCtD
Codeine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000249	0.00146	CcSEcCtD
Codeine—OPRD1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.000249	0.0146	CbGpPWpGaD
Codeine—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000248	0.00145	CcSEcCtD
Codeine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000248	0.00145	CcSEcCtD
Codeine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.00145	CcSEcCtD
Codeine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000248	0.00145	CcSEcCtD
Codeine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000248	0.00145	CcSEcCtD
Codeine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.00145	CcSEcCtD
Codeine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000247	0.00144	CcSEcCtD
Codeine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000247	0.00144	CcSEcCtD
Codeine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.00144	CcSEcCtD
Codeine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000247	0.0145	CbGpPWpGaD
Codeine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000246	0.00144	CcSEcCtD
Codeine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000246	0.00144	CcSEcCtD
Codeine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000246	0.00144	CcSEcCtD
Codeine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000245	0.00144	CcSEcCtD
Codeine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000245	0.00143	CcSEcCtD
Codeine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000245	0.00143	CcSEcCtD
Codeine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000244	0.00142	CcSEcCtD
Codeine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000244	0.00142	CcSEcCtD
Codeine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.00142	CcSEcCtD
Codeine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.00142	CcSEcCtD
Codeine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000243	0.00142	CcSEcCtD
Codeine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.00142	CcSEcCtD
Codeine—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000243	0.0164	CbGeAlD
Codeine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000242	0.00142	CcSEcCtD
Codeine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.00141	CcSEcCtD
Codeine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000241	0.00141	CcSEcCtD
Codeine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000241	0.00141	CcSEcCtD
Codeine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000241	0.00141	CcSEcCtD
Codeine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00024	0.0014	CcSEcCtD
Codeine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000239	0.0014	CcSEcCtD
Codeine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.0014	CcSEcCtD
Codeine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000239	0.0014	CcSEcCtD
Codeine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000239	0.0014	CcSEcCtD
Codeine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000239	0.00139	CcSEcCtD
Codeine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.00139	CcSEcCtD
Codeine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000238	0.00139	CcSEcCtD
Codeine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00139	CcSEcCtD
Codeine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00139	CcSEcCtD
Codeine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000237	0.00139	CcSEcCtD
Codeine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.00138	CcSEcCtD
Codeine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000236	0.00138	CcSEcCtD
Codeine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000236	0.00138	CcSEcCtD
Codeine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000235	0.00138	CcSEcCtD
Codeine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000235	0.00137	CcSEcCtD
Codeine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000235	0.00137	CcSEcCtD
Codeine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000235	0.00137	CcSEcCtD
Codeine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000234	0.00137	CcSEcCtD
Codeine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.00137	CcSEcCtD
Codeine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.00136	CcSEcCtD
Codeine—OPRK1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.000232	0.0136	CbGpPWpGaD
Codeine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000232	0.00136	CcSEcCtD
Codeine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000232	0.00135	CcSEcCtD
Codeine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000232	0.00135	CcSEcCtD
Codeine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.00135	CcSEcCtD
Codeine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.00135	CcSEcCtD
Codeine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.00135	CcSEcCtD
Codeine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00023	0.00134	CcSEcCtD
Codeine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00023	0.00134	CcSEcCtD
Codeine—CYP3A5—lung—acquired immunodeficiency syndrome	0.00023	0.0155	CbGeAlD
Codeine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00023	0.00134	CcSEcCtD
Codeine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.00134	CcSEcCtD
Codeine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000229	0.00134	CcSEcCtD
Codeine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000228	0.00134	CcSEcCtD
Codeine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000228	0.00134	CcSEcCtD
Codeine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000228	0.00133	CcSEcCtD
Codeine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000227	0.00133	CcSEcCtD
Codeine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00133	CcSEcCtD
Codeine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000227	0.00133	CcSEcCtD
Codeine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00133	CcSEcCtD
Codeine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000227	0.00132	CcSEcCtD
Codeine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000226	0.00132	CcSEcCtD
Codeine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000226	0.00132	CcSEcCtD
Codeine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.00131	CcSEcCtD
Codeine—OPRD1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000223	0.0131	CbGpPWpGaD
Codeine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.0013	CcSEcCtD
Codeine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.0013	CcSEcCtD
Codeine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000221	0.00129	CcSEcCtD
Codeine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.00129	CcSEcCtD
Codeine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000221	0.00129	CcSEcCtD
Codeine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00129	CcSEcCtD
Codeine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000221	0.00129	CcSEcCtD
Codeine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.00129	CcSEcCtD
Codeine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00022	0.00129	CcSEcCtD
Codeine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00022	0.00128	CcSEcCtD
Codeine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.00128	CcSEcCtD
Codeine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.00128	CcSEcCtD
Codeine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000219	0.00128	CcSEcCtD
Codeine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.00128	CcSEcCtD
Codeine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000219	0.00128	CcSEcCtD
Codeine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000219	0.00128	CcSEcCtD
Codeine—OPRK1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.000218	0.0128	CbGpPWpGaD
Codeine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.00127	CcSEcCtD
Codeine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.00127	CcSEcCtD
Codeine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.00127	CcSEcCtD
Codeine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000217	0.00127	CcSEcCtD
Codeine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000217	0.00127	CcSEcCtD
Codeine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.00127	CcSEcCtD
Codeine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000217	0.00127	CcSEcCtD
Codeine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000216	0.0127	CbGpPWpGaD
Codeine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000216	0.00126	CcSEcCtD
Codeine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.00125	CcSEcCtD
Codeine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.00125	CcSEcCtD
Codeine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000214	0.00125	CcSEcCtD
Codeine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.00124	CcSEcCtD
Codeine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.00124	CcSEcCtD
Codeine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000212	0.00124	CcSEcCtD
Codeine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000212	0.00124	CcSEcCtD
Codeine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.00124	CcSEcCtD
Codeine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000212	0.00124	CcSEcCtD
Codeine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000211	0.00124	CcSEcCtD
Codeine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000211	0.00123	CcSEcCtD
Codeine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.00123	CcSEcCtD
Codeine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00021	0.00123	CcSEcCtD
Codeine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00021	0.00123	CcSEcCtD
Codeine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.00123	CcSEcCtD
Codeine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.00123	CcSEcCtD
Codeine—Rash—Stavudine—acquired immunodeficiency syndrome	0.00021	0.00123	CcSEcCtD
Codeine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000209	0.00122	CcSEcCtD
Codeine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000209	0.00122	CcSEcCtD
Codeine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000209	0.00122	CcSEcCtD
Codeine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.00122	CcSEcCtD
Codeine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000208	0.00122	CcSEcCtD
Codeine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.00122	CcSEcCtD
Codeine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.00121	CcSEcCtD
Codeine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.00121	CcSEcCtD
Codeine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000207	0.00121	CcSEcCtD
Codeine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000207	0.00121	CcSEcCtD
Codeine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000206	0.0139	CbGeAlD
Codeine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000206	0.00121	CcSEcCtD
Codeine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00121	CcSEcCtD
Codeine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000205	0.0012	CcSEcCtD
Codeine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000204	0.0012	CcSEcCtD
Codeine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.00119	CcSEcCtD
Codeine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000203	0.0137	CbGeAlD
Codeine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.00119	CcSEcCtD
Codeine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.00118	CcSEcCtD
Codeine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.00118	CcSEcCtD
Codeine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.00118	CcSEcCtD
Codeine—OPRD1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000202	0.0118	CbGpPWpGaD
Codeine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.00117	CcSEcCtD
Codeine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.00117	CcSEcCtD
Codeine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.00117	CcSEcCtD
Codeine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.00117	CcSEcCtD
Codeine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.00117	CcSEcCtD
Codeine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.00117	CcSEcCtD
Codeine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.00116	CcSEcCtD
Codeine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000198	0.00116	CcSEcCtD
Codeine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000198	0.00116	CcSEcCtD
Codeine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000197	0.00115	CcSEcCtD
Codeine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.00115	CcSEcCtD
Codeine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000197	0.0132	CbGeAlD
Codeine—OPRM1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.000196	0.0115	CbGpPWpGaD
Codeine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.00114	CcSEcCtD
Codeine—OPRK1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000195	0.0115	CbGpPWpGaD
Codeine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.00114	CcSEcCtD
Codeine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000195	0.00114	CcSEcCtD
Codeine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.00113	CcSEcCtD
Codeine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.00113	CcSEcCtD
Codeine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000193	0.013	CbGeAlD
Codeine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.00113	CcSEcCtD
Codeine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000193	0.00113	CcSEcCtD
Codeine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.00113	CcSEcCtD
Codeine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.00113	CcSEcCtD
Codeine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.00112	CcSEcCtD
Codeine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.00112	CcSEcCtD
Codeine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.00112	CcSEcCtD
Codeine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.00112	CcSEcCtD
Codeine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000191	0.00112	CcSEcCtD
Codeine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00019	0.00111	CcSEcCtD
Codeine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.0011	CcSEcCtD
Codeine—OPRD1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000188	0.011	CbGpPWpGaD
Codeine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000187	0.00109	CcSEcCtD
Codeine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.00109	CcSEcCtD
Codeine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.00109	CcSEcCtD
Codeine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.00109	CcSEcCtD
Codeine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.00108	CcSEcCtD
Codeine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.00108	CcSEcCtD
Codeine—OPRM1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.000185	0.0108	CbGpPWpGaD
Codeine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.00108	CcSEcCtD
Codeine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000184	0.00107	CcSEcCtD
Codeine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.00107	CcSEcCtD
Codeine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.00107	CcSEcCtD
Codeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000183	0.0107	CbGpPWpGaD
Codeine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000182	0.00107	CcSEcCtD
Codeine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000182	0.00107	CcSEcCtD
Codeine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000182	0.00106	CcSEcCtD
Codeine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.00105	CcSEcCtD
Codeine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.00105	CcSEcCtD
Codeine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.00105	CcSEcCtD
Codeine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.00104	CcSEcCtD
Codeine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.00104	CcSEcCtD
Codeine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.00104	CcSEcCtD
Codeine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.00104	CcSEcCtD
Codeine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000178	0.00104	CcSEcCtD
Codeine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.00104	CcSEcCtD
Codeine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.00104	CcSEcCtD
Codeine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.00103	CcSEcCtD
Codeine—OPRK1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000177	0.0104	CbGpPWpGaD
Codeine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.00103	CcSEcCtD
Codeine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.00102	CcSEcCtD
Codeine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.001	CcSEcCtD
Codeine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.001	CcSEcCtD
Codeine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000172	0.001	CcSEcCtD
Codeine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000999	CcSEcCtD
Codeine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000999	CcSEcCtD
Codeine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000171	0.000999	CcSEcCtD
Codeine—OPRD1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000171	0.01	CbGpPWpGaD
Codeine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000994	CcSEcCtD
Codeine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000169	0.000991	CcSEcCtD
Codeine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000169	0.00099	CcSEcCtD
Codeine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000986	CcSEcCtD
Codeine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.000982	CcSEcCtD
Codeine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000968	CcSEcCtD
Codeine—OPRM1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000165	0.0097	CbGpPWpGaD
Codeine—OPRK1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000165	0.00967	CbGpPWpGaD
Codeine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000958	CcSEcCtD
Codeine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000953	CcSEcCtD
Codeine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000953	CcSEcCtD
Codeine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.000944	CcSEcCtD
Codeine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000942	CcSEcCtD
Codeine—OPRM1—IL4-mediated signaling events—CD40LG—acquired immunodeficiency syndrome	0.000161	0.00946	CbGpPWpGaD
Codeine—OPRM1—IL4-mediated signaling events—IL10—acquired immunodeficiency syndrome	0.000161	0.00946	CbGpPWpGaD
Codeine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.000939	CcSEcCtD
Codeine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.000936	CcSEcCtD
Codeine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.000935	CcSEcCtD
Codeine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00016	0.000933	CcSEcCtD
Codeine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.00016	0.0107	CbGeAlD
Codeine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000931	CcSEcCtD
Codeine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000929	CcSEcCtD
Codeine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000157	0.0106	CbGeAlD
Codeine—OPRM1—IL4-mediated signaling events—IL4—acquired immunodeficiency syndrome	0.000157	0.0092	CbGpPWpGaD
Codeine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000907	CcSEcCtD
Codeine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000903	CcSEcCtD
Codeine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000154	0.0103	CbGeAlD
Codeine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000896	CcSEcCtD
Codeine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000895	CcSEcCtD
Codeine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000894	CcSEcCtD
Codeine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000889	CcSEcCtD
Codeine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000151	0.0102	CbGeAlD
Codeine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.000882	CcSEcCtD
Codeine—OPRK1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.00015	0.00878	CbGpPWpGaD
Codeine—OPRD1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00015	0.00878	CbGpPWpGaD
Codeine—OPRM1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000149	0.00877	CbGpPWpGaD
Codeine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000869	CcSEcCtD
Codeine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000865	CcSEcCtD
Codeine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000853	CcSEcCtD
Codeine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000844	CcSEcCtD
Codeine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000836	CcSEcCtD
Codeine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000835	CcSEcCtD
Codeine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000828	CcSEcCtD
Codeine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000827	CcSEcCtD
Codeine—OPRM1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000139	0.00818	CbGpPWpGaD
Codeine—OPRD1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000138	0.00808	CbGpPWpGaD
Codeine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000804	CcSEcCtD
Codeine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000798	CcSEcCtD
Codeine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000797	CcSEcCtD
Codeine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000796	CcSEcCtD
Codeine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000135	0.00794	CbGpPWpGaD
Codeine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.00078	CcSEcCtD
Codeine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000767	CcSEcCtD
Codeine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000131	0.0077	CbGpPWpGaD
Codeine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.00076	CcSEcCtD
Codeine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.00076	CcSEcCtD
Codeine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000751	CcSEcCtD
Codeine—OPRM1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000126	0.00742	CbGpPWpGaD
Codeine—OPRD1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000125	0.00731	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—TAT—acquired immunodeficiency syndrome	0.000124	0.0073	CbGpPWpGaD
Codeine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000716	CcSEcCtD
Codeine—OPRK1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000121	0.00709	CbGpPWpGaD
Codeine—CYP2D6—brain—acquired immunodeficiency syndrome	0.00012	0.00808	CbGeAlD
Codeine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000119	0.00696	CbGpPWpGaD
Codeine—OPRM1—TCR Signaling Pathway—CD8A—acquired immunodeficiency syndrome	0.000118	0.00694	CbGpPWpGaD
Codeine—OPRD1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000117	0.00687	CbGpPWpGaD
Codeine—OPRD1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000117	0.00687	CbGpPWpGaD
Codeine—OPRD1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000114	0.00668	CbGpPWpGaD
Codeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000111	0.00651	CbGpPWpGaD
Codeine—OPRK1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000109	0.00641	CbGpPWpGaD
Codeine—OPRM1—TCR Signaling Pathway—CCR5—acquired immunodeficiency syndrome	0.000108	0.00635	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000106	0.00621	CbGpPWpGaD
Codeine—OPRD1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000105	0.00617	CbGpPWpGaD
Codeine—OPRD1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000103	0.00605	CbGpPWpGaD
Codeine—OPRK1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000103	0.00603	CbGpPWpGaD
Codeine—OPRK1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000103	0.00603	CbGpPWpGaD
Codeine—OPRM1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000102	0.00599	CbGpPWpGaD
Codeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.0001	0.00588	CbGpPWpGaD
Codeine—OPRK1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	9.98e-05	0.00586	CbGpPWpGaD
Codeine—OPRD1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	9.88e-05	0.0058	CbGpPWpGaD
Codeine—OPRD1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	9.88e-05	0.0058	CbGpPWpGaD
Codeine—OPRD1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	9.75e-05	0.00572	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	9.64e-05	0.00566	CbGpPWpGaD
Codeine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	9.24e-05	0.00542	CbGpPWpGaD
Codeine—OPRM1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	9.23e-05	0.00542	CbGpPWpGaD
Codeine—OPRK1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	9.21e-05	0.00541	CbGpPWpGaD
Codeine—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	9.17e-05	0.00538	CbGpPWpGaD
Codeine—OPRK1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	9.03e-05	0.0053	CbGpPWpGaD
Codeine—OPRD1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	8.91e-05	0.00523	CbGpPWpGaD
Codeine—OPRM1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	8.68e-05	0.00509	CbGpPWpGaD
Codeine—OPRM1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	8.68e-05	0.00509	CbGpPWpGaD
Codeine—OPRK1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	8.66e-05	0.00509	CbGpPWpGaD
Codeine—OPRK1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	8.66e-05	0.00509	CbGpPWpGaD
Codeine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	8.55e-05	0.00502	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	8.46e-05	0.00496	CbGpPWpGaD
Codeine—OPRM1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	8.44e-05	0.00495	CbGpPWpGaD
Codeine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	8.35e-05	0.0049	CbGpPWpGaD
Codeine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	8.1e-05	0.00476	CbGpPWpGaD
Codeine—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	8.04e-05	0.00472	CbGpPWpGaD
Codeine—OPRD1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	8.03e-05	0.00471	CbGpPWpGaD
Codeine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	7.85e-05	0.00461	CbGpPWpGaD
Codeine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	7.85e-05	0.00461	CbGpPWpGaD
Codeine—OPRK1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	7.81e-05	0.00459	CbGpPWpGaD
Codeine—OPRM1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	7.79e-05	0.00457	CbGpPWpGaD
Codeine—OPRM1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	7.63e-05	0.00448	CbGpPWpGaD
Codeine—OPRD1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	7.52e-05	0.00441	CbGpPWpGaD
Codeine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	7.33e-05	0.0043	CbGpPWpGaD
Codeine—OPRM1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	7.32e-05	0.0043	CbGpPWpGaD
Codeine—OPRM1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	7.32e-05	0.0043	CbGpPWpGaD
Codeine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	7.23e-05	0.00424	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	7.15e-05	0.0042	CbGpPWpGaD
Codeine—OPRK1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	7.04e-05	0.00413	CbGpPWpGaD
Codeine—OPRD1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	7.03e-05	0.00413	CbGpPWpGaD
Codeine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	6.89e-05	0.00404	CbGpPWpGaD
Codeine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	6.89e-05	0.00404	CbGpPWpGaD
Codeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	6.85e-05	0.00402	CbGpPWpGaD
Codeine—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	6.79e-05	0.00399	CbGpPWpGaD
Codeine—OPRM1—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	6.79e-05	0.00399	CbGpPWpGaD
Codeine—OPRD1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	6.77e-05	0.00397	CbGpPWpGaD
Codeine—OPRM1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	6.6e-05	0.00388	CbGpPWpGaD
Codeine—OPRK1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	6.59e-05	0.00387	CbGpPWpGaD
Codeine—OPRD1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	6.36e-05	0.00373	CbGpPWpGaD
Codeine—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	6.28e-05	0.00369	CbGpPWpGaD
Codeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	6.19e-05	0.00363	CbGpPWpGaD
Codeine—OPRK1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	6.17e-05	0.00362	CbGpPWpGaD
Codeine—OPRD1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	5.98e-05	0.00351	CbGpPWpGaD
Codeine—OPRD1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	5.98e-05	0.00351	CbGpPWpGaD
Codeine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	5.98e-05	0.00351	CbGpPWpGaD
Codeine—OPRM1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	5.95e-05	0.00349	CbGpPWpGaD
Codeine—OPRK1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	5.94e-05	0.00349	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	5.84e-05	0.00343	CbGpPWpGaD
Codeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	5.82e-05	0.00342	CbGpPWpGaD
Codeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	5.82e-05	0.00342	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	5.7e-05	0.00334	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—TAT—acquired immunodeficiency syndrome	5.66e-05	0.00333	CbGpPWpGaD
Codeine—OPRK1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	5.58e-05	0.00327	CbGpPWpGaD
Codeine—OPRM1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	5.57e-05	0.00327	CbGpPWpGaD
Codeine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	5.51e-05	0.00323	CbGpPWpGaD
Codeine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	5.38e-05	0.00316	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	5.28e-05	0.0031	CbGpPWpGaD
Codeine—OPRK1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	5.24e-05	0.00308	CbGpPWpGaD
Codeine—OPRK1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	5.24e-05	0.00308	CbGpPWpGaD
Codeine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	5.24e-05	0.00308	CbGpPWpGaD
Codeine—OPRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	5.21e-05	0.00306	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	5.12e-05	0.00301	CbGpPWpGaD
Codeine—OPRM1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	5.02e-05	0.00295	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	5e-05	0.00293	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—AGPS—acquired immunodeficiency syndrome	4.82e-05	0.00283	CbGpPWpGaD
Codeine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	4.72e-05	0.00277	CbGpPWpGaD
Codeine—OPRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	4.71e-05	0.00277	CbGpPWpGaD
Codeine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	4.66e-05	0.00273	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	4.63e-05	0.00272	CbGpPWpGaD
Codeine—OPRD1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	4.55e-05	0.00267	CbGpPWpGaD
Codeine—OPRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	4.43e-05	0.0026	CbGpPWpGaD
Codeine—OPRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	4.43e-05	0.0026	CbGpPWpGaD
Codeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	4.43e-05	0.0026	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	4.33e-05	0.00254	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	4.22e-05	0.00248	CbGpPWpGaD
Codeine—OPRD1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	4.1e-05	0.00241	CbGpPWpGaD
Codeine—OPRK1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	3.99e-05	0.00234	CbGpPWpGaD
Codeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	3.99e-05	0.00234	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	3.92e-05	0.0023	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—TAT—acquired immunodeficiency syndrome	3.87e-05	0.00227	CbGpPWpGaD
Codeine—OPRM1—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	3.67e-05	0.00216	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.61e-05	0.00212	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—TAT—acquired immunodeficiency syndrome	3.6e-05	0.00211	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.6e-05	0.00211	CbGpPWpGaD
Codeine—OPRK1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	3.59e-05	0.00211	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.45e-05	0.00203	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.45e-05	0.00203	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.38e-05	0.00198	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.38e-05	0.00198	CbGpPWpGaD
Codeine—OPRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	3.37e-05	0.00198	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—AGPS—acquired immunodeficiency syndrome	3.29e-05	0.00193	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.26e-05	0.00192	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.17e-05	0.00186	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.15e-05	0.00185	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.12e-05	0.00183	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.07e-05	0.0018	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.07e-05	0.0018	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.06e-05	0.0018	CbGpPWpGaD
Codeine—OPRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	3.04e-05	0.00178	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.03e-05	0.00178	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.03e-05	0.00178	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.96e-05	0.00174	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.96e-05	0.00174	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.86e-05	0.00168	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	2.8e-05	0.00164	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.74e-05	0.00161	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.69e-05	0.00158	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.69e-05	0.00158	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.68e-05	0.00157	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.66e-05	0.00156	CbGpPWpGaD
Codeine—SLC22A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.64e-05	0.00155	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.57e-05	0.00151	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.56e-05	0.0015	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.56e-05	0.0015	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.53e-05	0.00149	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.5e-05	0.00147	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.5e-05	0.00147	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.42e-05	0.00142	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	2.38e-05	0.0014	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.34e-05	0.00137	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.32e-05	0.00136	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.31e-05	0.00136	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.3e-05	0.00135	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.27e-05	0.00134	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.27e-05	0.00134	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.25e-05	0.00132	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.22e-05	0.0013	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—ALB—acquired immunodeficiency syndrome	2.17e-05	0.00127	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.13e-05	0.00125	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.1e-05	0.00124	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.05e-05	0.0012	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.03e-05	0.00119	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.02e-05	0.00118	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	1.99e-05	0.00117	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.93e-05	0.00113	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.91e-05	0.00112	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.88e-05	0.0011	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.87e-05	0.0011	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.84e-05	0.00108	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.81e-05	0.00106	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.81e-05	0.00106	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.73e-05	0.00102	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.72e-05	0.00101	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.7e-05	0.001	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.69e-05	0.000993	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.69e-05	0.000993	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.59e-05	0.000933	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.59e-05	0.000933	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.58e-05	0.000928	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.56e-05	0.000915	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.43e-05	0.000839	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.38e-05	0.00081	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.36e-05	0.000798	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.34e-05	0.000789	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.34e-05	0.000789	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.34e-05	0.000787	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.34e-05	0.000786	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.3e-05	0.000764	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.24e-05	0.00073	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.22e-05	0.000714	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.21e-05	0.00071	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.19e-05	0.000699	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.17e-05	0.000689	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.11e-05	0.000649	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.09e-05	0.00064	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.07e-05	0.000626	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.02e-05	0.0006	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.01e-05	0.000591	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.92e-06	0.000582	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—ALB—acquired immunodeficiency syndrome	9.88e-06	0.00058	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.21e-06	0.000541	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.01e-06	0.000529	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.18e-06	0.000422	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.14e-06	0.000419	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	6.75e-06	0.000396	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.3e-06	0.00037	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—ALB—acquired immunodeficiency syndrome	6.28e-06	0.000369	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.26e-06	0.000368	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.32e-06	0.000312	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.29e-06	0.000311	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	4.88e-06	0.000286	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.22e-06	0.000248	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.7e-06	0.000217	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	3.47e-06	0.000204	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.13e-06	0.000184	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.27e-06	0.000133	CbGpPWpGaD
